Coronavirus Report – Part 77: Japan’s Pharmaceutical Companies Move in Quick Order to Treat Infection May. 19, 2020
Coronavirus Report – Part 67: Pandemic Causes 75% Drop in Clinical Trials for Early April May. 7, 2020
Coronavirus Report – Part 66: Pfizer Japan President Akihisa Harada Discusses Pharmaceutical Approach to Battling Pandemic May. 7, 2020
Coronavirus Report – Part 61: Ube Industries to Begin Supplying Intermediate for Avigan Apr. 27, 2020
Coronavirus Report – Part 48: Stagnation of Chinese Pharmaceutical Intermediates Causes Market Disruption Apr. 20, 2020
Medical & Biological Laboratories to Commercially Launch Development Services in Companion Diagnostics Dec. 10, 2018
Lightnix, Tokyo University of Science Develop Biodegradable Resin Needle for Vaccinations Nov. 13, 2018
